EKF Diagnostics: looking good, but what next?
Much like every business touching the Covid-19 testing space, shares in EKF Diagnostic (LON:EKF), the global medical manufacturer of point-of-care and central lab devices and chemistry reagents, have had an excellent run over recent months.
The latest trading update confirmed that that full year performance remains in-line with management expectations, which have already been revised upwards several times this year.
While their PrimeStore MTM COVID-19 sample collection device has been…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Arcontech Group
27/10/2023 · Company Insights
Several companies covered here have growing cash piles – for one cash represents more than half…
01/09/2021 · Company Insights
Two companies covered here supporting the hospitality sector have experienced contrasting fortunes over the year, with…
More on EKF Diagnostics Holdings
12/01/2021 · Company Insights
There are a broad range of trading updates covered here, but we can’t understand why one company bothered, when…
09/11/2020 · Company Insights
Two pioneering companies supporting the renewable energy arena announced positive developments for their rapidly developing technologies.
More Company Insights
Elderly companies growth struggles while the vets find joy down-under
New CEO to drive this highly innovative business
Our assessment of results highlights some questionable businesses
More on Arcontech Group
More on EKF Diagnostics Holdings
More Company Insights